Entourage Health Corp.

    Entourage Health Corp.

    TTSXV:ENTG
    - -
    CAD
    - -
    - -

    Share Statistics

    As of September 30, 2024, Entourage Health Corp. has 308.39M shares outstanding.

    Shares Outstanding308.39M

    Valuation Ratios

    These figures are as of September 30, 2024. The price-to-sales ratio is 0.07, and the price-to-book ratio stands at -0.02.

    PS Ratio0.07
    PB Ratio-0.02
    P/TBV Ratio-0.02
    P/FCF Ratio-0.65
    P/OCF Ratio-0.57

    Enterprise Valuation

    These figures are as of September 30, 2024. The EV/Sales ratio of 4.37 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Entourage Health Corp. trades at an EV/FCF ratio of 8.14, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

    EV / Sales4.37
    EV / FCF8.14

    Financial Position

    As of September 30, 2024, Entourage Health Corp. maintains a current ratio of 0.10, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -105.57, indicating conservative leverage, while an interest coverage ratio of -0.56 demonstrates limited ability to service its debt obligations.

    Current Ratio0.10
    Quick Ratio0.04
    Debt / Equity-105.57
    Debt / EBITDA-12.07
    Interest Coverage-0.56

    Financial Efficiency

    These figures cover the twelve months ended September 30, 2024. Return on assets (ROA) is negative at -132.85, reflecting losses generated across the asset base. Inventory turnover of 2.79 indicates how many times Entourage Health Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

    Return on Assets (ROA)-132.85
    Inventory Turnover2.79

    Margins

    Over the twelve months ended September 30, 2024, Entourage Health Corp. posted a gross margin of 10.21, reflecting its pricing power and cost economics. The operating margin of -37.88 and net profit margin of -101.69 provide insight into operational efficiency.

    Gross Margin10.21
    Operating Margin-37.88
    Pretax Margin-101.69
    Profit Margin-101.69
    EBITDA Margin-36.34

    Dividends & Yields

    These figures cover the twelve months ended September 30, 2024. Free cash flow yield is negative at -153.88: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 9.33, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Entourage Health Corp. shareholders.

    Shareholder Yield9.33
    FCF Yield-153.88

    Scores

    As of September 30, 2024, Entourage Health Corp. has an Altman Z-Score of -30.90, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

    Altman Z-Score-30.90